Cargando…

Relationships Between Allopurinol Dose, Oxypurinol Concentration and Urate‐Lowering Response—In Search of a Minimum Effective Oxypurinol Concentration

The aims of this study were to determine factors that predict serum urate (SU) lowering response to allopurinol and the conversion of allopurinol to oxypurinol, and to determine a minimum therapeutic oxypurinol concentration. Data from 129 participants in a 24‐month open, randomized, controlled, par...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stamp, Lisa K., Chapman, Peter T., Barclay, Murray, Horne, Anne, Frampton, Christopher, Merriman, Tony R., Wright, Daniel F. B., Drake, Jill, Dalbeth, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951452/ https://www.ncbi.nlm.nih.gov/pubmed/31444839 http://dx.doi.org/10.1111/cts.12686

Ejemplares similares

The impact of genetic variability in urate transporters on oxypurinol pharmacokinetics
por: Hishe, Hailemichael Z., et al.
Publicado: (2022)

Allopurinol and oxypurinol promote osteoblast differentiation and increase bone formation
por: Orriss, Isabel R., et al.
Publicado: (2016)

Allopurinol and oxypurinol differ in their strength and mechanisms of inhibition of xanthine oxidoreductase
por: Sekine, Mai, et al.
Publicado: (2023)

Females present higher dose‐adjusted drug concentrations of metoprolol and allopurinol/oxypurinol than males
por: Hindi, Jessica, et al.
Publicado: (2023)

The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial
por: Stamp, Lisa K., et al.
Publicado: (2017)

How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose
por: Stamp, Lisa K., et al.
Publicado: (2018)

Simultaneous analysis of allopurinol and oxypurinol using a validated liquid chromatography–tandem mass spectrometry method in human plasma
por: Rathod, Dhiraj M., et al.
Publicado: (2017)

Pharmacokinetic/Pharmacodynamic Modelling of Allopurinol, its Active Metabolite Oxypurinol, and Biomarkers Hypoxanthine, Xanthine and Uric Acid in Hypoxic-Ischemic Encephalopathy Neonates
por: Chu, Wan-Yu, et al.
Publicado: (2021)

Eicosapentaenoic Acid and Oxypurinol in the Treatment of Muscle Wasting in a Mouse Model of Cancer Cachexia
por: Vaughan, Vanessa C., et al.
Publicado: (2012)

Oxypurinol protects renal ischemia/reperfusion injury via heme oxygenase-1 induction
por: Kang, Hye Bin, et al.
Publicado: (2023)

Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout
por: Dalbeth, Nicola, et al.
Publicado: (2015)

Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis
por: Robinson, Philip C., et al.
Publicado: (2021)

Ultra-performance hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry for simultaneous determination of allopurinol, oxypurinol and lesinurad in rat plasma: Application to pharmacokinetic study in rats
por: Iqbal, Muzaffar, et al.
Publicado: (2019)

Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics
por: Vora, Bianca, et al.
Publicado: (2021)

Direct injection analysis of oxypurinol and metformin in wastewater by hydrophilic interaction liquid chromatography coupled to tandem mass spectrometry
por: Zheng, Qiuda, et al.
Publicado: (2022)

Impact of allopurinol use on urate concentration and cardiovascular outcome
por: Wei, Li, et al.
Publicado: (2011)

Interactions between serum urate-associated genetic variants and sex on gout risk: analysis of the UK Biobank
por: Narang, Ravi K., et al.
Publicado: (2019)

Effect of body mass index on serum urate and renal uric acid handling responses to an oral inosine load: experimental intervention study in healthy volunteers
por: Dalbeth, Nicola, et al.
Publicado: (2020)

Effects of elevated serum urate on cardiometabolic and kidney function markers in a randomised clinical trial of inosine supplementation
por: Dalbeth, Nicola, et al.
Publicado: (2022)

Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women
por: Topless, Ruth K., et al.
Publicado: (2015)

The relationship between ferritin and urate levels and risk of gout
por: Fatima, Tahzeeb, et al.
Publicado: (2018)

Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
por: Sun, Mingyao, et al.
Publicado: (2022)

Association analysis of the SLC22A11 (organic anion transporter 4) and SLC22A12 (urate transporter 1) urate transporter locus with gout in New Zealand case-control sample sets reveals multiple ancestral-specific effects
por: Flynn, Tanya J, et al.
Publicado: (2013)

Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol
por: Dalbeth, Nicola, et al.
Publicado: (2018)

Persistence with urate‐lowering therapy in Australia: A longitudinal analysis of allopurinol prescriptions
por: Coleshill, Matthew J., et al.
Publicado: (2022)

Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
por: Stamp, Lisa K., et al.
Publicado: (2022)

Influence of the ABCG2 gout risk 141 K allele on urate metabolism during a fructose challenge
por: Dalbeth, Nicola, et al.
Publicado: (2014)

Is repeat serum urate testing superior to a single test to predict incident gout over time?
por: Stewart, Sarah, et al.
Publicado: (2022)

Positive association of tomato consumption with serum urate: support for tomato consumption as an anecdotal trigger of gout flares
por: Flynn, Tanya J, et al.
Publicado: (2015)

Gout Remission as a Goal of Urate-Lowering Therapy: A Critical Review
por: Tabi-Amponsah, Adwoa Dansoa, et al.
Publicado: (2023)

Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
por: Dalbeth, Nicola, et al.
Publicado: (2012)

Evaluation of the diet wide contribution to serum urate levels: meta-analysis of population based cohorts
por: Major, Tanya J, et al.
Publicado: (2018)

Sugar-sweetened beverage consumption: a risk factor for prevalent gout with SLC2A9 genotype-specific effects on serum urate and risk of gout
por: Batt, Caitlin, et al.
Publicado: (2014)

The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion
por: Hoque, Kazi Mirajul, et al.
Publicado: (2020)

The renal urate transporter SLC17A1 locus: confirmation of association with gout
por: Hollis-Moffatt, Jade E, et al.
Publicado: (2012)

Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress
por: George, Jacob, et al.
Publicado: (2009)

Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study
por: Towiwat, Patapong, et al.
Publicado: (2016)

The genetics of gout: towards personalised medicine?
por: Dalbeth, Nicola, et al.
Publicado: (2017)

Comparative effectiveness of urate lowering with febuxostat versus allopurinol in gout: analyses from large U.S. managed care cohort
por: Singh, Jasvinder A, et al.
Publicado: (2015)

Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
por: Wrigley, Rebekah, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i43dqtv0j2g4u8luj70u8jhohd